rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-12-12
|
pubmed:abstractText |
Introducing irinotecan and oxaliplatin in to the treatment of advanced colorectal cancer substantially improved the therapeutic results for this malignancy. The first results of clinical trials with these two drugs were published in 2000.
|
pubmed:language |
cze
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0008-7335
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
747-51; discussion 752
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16335701-Adult,
pubmed-meshheading:16335701-Aged,
pubmed-meshheading:16335701-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16335701-Camptothecin,
pubmed-meshheading:16335701-Carcinoma,
pubmed-meshheading:16335701-Colorectal Neoplasms,
pubmed-meshheading:16335701-Female,
pubmed-meshheading:16335701-Fluorouracil,
pubmed-meshheading:16335701-Humans,
pubmed-meshheading:16335701-Leucovorin,
pubmed-meshheading:16335701-Male,
pubmed-meshheading:16335701-Middle Aged
|
pubmed:year |
2005
|
pubmed:articleTitle |
[Irinotecan in combination with 5-fluorouracil and leucovorin in the treatment of metastatic colorectal cancer].
|
pubmed:affiliation |
Radioterapeuticko-onkologické odd?lení 2. LF UK a FNM, Praha. jana.prausova@lfmotol.cuni.cz
|
pubmed:publicationType |
Journal Article,
English Abstract
|